YSYang-Chin Su

Yang-Chin Su

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yang-Chin Su has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Chen-Huan Chen

    Department of Anesthesiology, Taipei Medical University Hospital, Taipei Medical University, No. 252, Wuxing St, Xinyi District, Taipei 110301, Taiwan, ROC; Department of Education and Humanities in Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wuxing St, Xinyi District, Taipei 110301, Taiwan, ROC

    1 shared publication
  • Chern-En Chiang

    General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan, ROC

    1 shared publication
  • Chi-Jung Huang

    Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

    1 shared publication
  • Chi-Kuang Feng

    Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan

    1 shared publication
  • Hao-Min Cheng

    Department of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

    1 shared publication
  • Shih-Hsien Sung

    Cardiovascular Center, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Assessment and Management of Adolescent Idiopathic Scoliosis: From the Perspective of a Physiatrist

    by Yang-Chin Su, Chi-Kuang Feng, Tsui-Fen Yang

    Adolescent idiopathic scoliosis (AIS) is the most encountered spinal deformity in growing children, which may bring significant impacts on patients’ physical function, appearance, and overall quality of life. A physiatrist plays a crucial role in the early diagnosis of AIS and longitudinal management through continuous care. Contemporary management for AIS is according to the skeletal maturity, the magnitude of the spinal curves, and the risk of progression. For mild curves, therapeutic exercises, particularly physiotherapeutic scoliosis-specific exercises (PSSE), are employed as a conservative approach to improve postural symmetry and reduce the risk of curve progression. Bracing is required for moderate curves from 25 to 45 degrees in skeletally immature cases. Strict compliance with bracing is critical for therapeutic success. In cases that are rapidly progressive or in severe curves exceeding 40 to 45 degrees, spinal fusion surgery is considered the definitive treatment. Recent advancements in non-fusion and motion-preserving techniques provide alternative options to traditional fusion surgery. To protect maximal neurological function, intraoperative neurophysiological monitoring (IONM) is currently the trend for spinal deformity correction surgery. The care for AIS patients is an individualized, multidisciplinary, patient-centered, growth-sensitive approach, aiming to optimize outcomes and minimize long-term complications. This review outlines a comprehensive rehabilitation-oriented strategy for AIS patients from the perspective of a physiatrist, encompassing clinical assessment, conservative management with observation, therapeutic exercises, bracing, and further considerations in referral to spinal surgery.


  • Open Access

    Effectiveness of salt substitute on cardiovascular outcomes: A systematic review and meta‐analysis

    by Yi‐Ching Tsai, Yen‐Po Tsao, Chi‐Jung Huang, Yen‐Hsuan Tai, Yang‐Chin Su, Chern‐En Chiang, Shih‐Hsien Sung, Chen‐Huan Chen, Hao‐Min Cheng

    Hypertension‐related death is the leading cause of mortality worldwide, making blood pressure (BP) control an important issue. Salt substitute is a non‐pharmaceutical strategy to improve hypertension control. The goal of this study was to evaluate the effect of salt substitute on BP and cardiovascular disease. The authors searched the Cochrane Library and PubMed databases through March 2022, and assessed the risk‐of‐bias for included studies by the Cochrane risk‐of‐bias tool. Twenty‐three randomized controlled trials with 32073 patients were included in our systematic review. A meta‐analysis with random effects was performed to analyze the effects of salt substitute on systolic and diastolic BP, 24‐h urinary sodium and potassium, and cardiovascular and all‐cause mortality. In the random‐effects model, participants consuming salt substitute showed significant reduction in systolic BP (mean difference (MD) −4.80 mmHg, 95% confidence interval (CI) −6.12 to −3.48, P < 0.0001) and diastolic BP (MD −1.48 mmHg, 95% CI −2.06 to −0.90, P < 0.0001) compared with participants consuming normal salt. In the urine electrolyte analysis, the salt substitute group had significant reduction in 24‐h urine sodium (MD −22.96 mmol/24‐h, P = 0.0001) and significant elevation in 24‐h urine potassium (MD 14.41 mmol/24‐h, P < 0.0001). Of the five studies with mortality outcome data, salt substitute significantly reduced all‐cause mortality (hazard ratio 0.88, P = 0.0003). In conclusion, our analyses showed that salt substitute has a strong effect on lowering BP and reducing all‐cause mortality. By modifying the daily diet with salt substitute, the authors can improve BP control by using this non‐pharmaceutical management.